Inside 3D cell culture with Catherine Siler
In recent years there has been a marked increase in the use of spheroids for various applications, including in the development of advanced therapies. In this interview, Catherine Siler from Corning Life Sciences (MA, USA) discusses why this might be and explains how different culturing systems impact factors such as the number of spheroids produced and their uniformity, as well as giving us an insight into how the Elplasia 12K flask works compared to current methods for producing spheroids.
Catherine Siler
Catherine Siler is an accomplished Field Application Scientist for Corning Life Sciences (MA, USA) with a PhD in Biology from Johns Hopkins University (MD, USA). Dr. Siler enables scientists and researchers in the life science industry to overcome challenges with cell culture and scale-up for clinical manufacturing of advanced therapies. She utilizes her research and teaching experience to drive the adoption of an industry-leading global product portfolio of innovative single-use consumables for research, process development and bioprocessing applications.
This interview was recorded on Tuesday 18 April 2023.
In association with
